SPRO - Spero Therapeutics, Inc.
IEX Last Trade
1.03
0 0%
Share volume: 1,472
Last Updated: Fri 27 Dec 2024 08:27:37 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$1.03
0.00
0.00%
Summary score
22%
Profitability
25%
Dept financing
5%
Liquidity
50%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-19.73%
Return on assets
-15.7%
Return on sales
0%
Return on invested capital
110.03%
Total debt ratio
15.6%
Debt ratio change over timeo
-0.95%
Current Ratio
9.42%
Quick Ratio
0%
Cash Position Ratio
5.33%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-26.31%
Return on assets
-20.02%
Return on sales
0%
Return on invested capital
226.92%
Total debt ratio
24.19%
Debt ratio change over timeo
-0.91%
Current Ratio
4.82%
Quick Ratio
0%
Cash Position Ratio
2.6%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-23.74%
Return on assets
-18.94%
Return on sales
0%
Return on invested capital
259.16%
Total debt ratio
24.43%
Debt ratio change over time
-0.89%
Current Ratio
4.49%
Quick Ratio
0%
Cash Position Ratio
3.44%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-105.81%
Return on assets
-104.82%
Return on sales
0%
Return on invested capital
-15.65%
Total debt ratio
-94.65%
Debt ratio change over time
-0.95%
Current Ratio
2.44%
Quick Ratio
0%
Cash Position Ratio
0.63%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SPRO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -19.73% | -3.05% | 11.55% | 6.27% |
| Return on assets | -15.7% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 110.03% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 69% | 61% |
| Total debt ratio | 15.6% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.95% | 6.09% | 6.03% | 1.53% |
| Dept financing | 4% | 50% | 43% | 14% |
| Current Ratio | 4.82% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.6% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 18% | 37% | 39% |
| Short-term ratios | SPRO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -26.31% | -25.62% | 17.94% | 7.14% |
| Return on assets | -20.02% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 226.92% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 39% | 70% | 59% |
| Total debt ratio | 24.19% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.91% | -23.44% | 9.66% | 0.6% |
| Dept financing | 6% | 25% | 45% | 8% |
| Current Ratio | 4.82% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.6% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 42% | 33% | 58% |